Evaluation of Regenerative Endodontic Treatment for Immature Teeth

NCT ID: NCT07210359

Last Updated: 2025-10-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-15

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to evaluate if regenerative endodontic treatment using two different forms of demineralized dentin matrix (DDM) can effectively treat immature permanent single-rooted teeth compared to treatment using RetroMTA in patients aged 9 to 15 years. The main questions it aims to answer are:

Does the use of DDM improve clinical and radiographic outcomes such as root length, dentinal wall thickness, and apex closure?

Is DDM a viable bioactive alternative to RetroMTA as a coronal sealing material in regenerative endodontic procedures?

Researchers will compare three groups: one using RetroMTA, one using a DDM-TheraCal LC mixture, and one using TDM-Hydrogel, to see if these materials differ in their effects on regenerative outcomes.

Participants will:

Undergo two treatment visits including canal disinfection, induction of bleeding to form a blood clot scaffold,

Receive placement of one of the study materials over the blood clot as a coronal barrier,

Have clinical examinations and CBCT imaging at baseline and multiple follow-ups up to 12 months to assess treatment success through signs, symptoms, and radiographic changes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study was conducted as a split-mouth randomized clinical trial, approved by research ethics committee, Faculty of Dentistry, Kafrelsheikh University, and carried out at Endodontic Department, Faculty of Dentistry, Kafrelsheikh University. 36 patients of both sexes aged from 9 to 15 years old were selected with an immature teeth with teeth diagnosed as either vital (asymptomatic irreversible pulpitis or symptomatic irreversible pulpitis and the bleeding didn't stop after 5 minutes application of hemostatic agent) or non-vital pulp are indicated for regenerative endodontic procedure.

Patients will be divided randomly into three equal groups (n = 12):

Group 1(control group): Revascularization will be done using blood clot and RetroMTA as coronal barrier.

Group 2: Revascularization will be done using blood clot and DDM-TheraCal LC mixture paste as coronal barrier.

Group 3: Revascularization will be done using blood clot and TDM-Hydrogel as coronal barrier.

CBCT image will be obtained for baseline records before treatment and after placement of the final resin restoration, then the patients will be recalled after 3, 6, 9 and 12 months for evaluating any changes in dentin bridge formation, root length, root canal width, apex diameter and lesion size if present.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulpal Necrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

treated hyman dentin matrix hydrogel

material used for regenerative dentistry

Group Type ACTIVE_COMPARATOR

Theracal LC - Demineralized dentin matrix combination

Intervention Type PROCEDURE

material used for regenerative dentistry

Retro Mta

Intervention Type PROCEDURE

material used for regenerative dentistry

Theracal LC- Demineralized dentina matrix combination

material used for regenerative dentistry

Group Type ACTIVE_COMPARATOR

human treated dentin matrix hydrogel

Intervention Type PROCEDURE

material used for regenerative dentistry

Retro Mta

Intervention Type PROCEDURE

material used for regenerative dentistry

RetroMTA

material used for regenerative dentistry

Group Type ACTIVE_COMPARATOR

human treated dentin matrix hydrogel

Intervention Type PROCEDURE

material used for regenerative dentistry

Theracal LC - Demineralized dentin matrix combination

Intervention Type PROCEDURE

material used for regenerative dentistry

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

human treated dentin matrix hydrogel

material used for regenerative dentistry

Intervention Type PROCEDURE

Theracal LC - Demineralized dentin matrix combination

material used for regenerative dentistry

Intervention Type PROCEDURE

Retro Mta

material used for regenerative dentistry

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

demineralized dentin matrix

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Systemically healthy patients (i.e., free of any systemic diseases).
* Patients presenting with immature permanent single-rooted teeth.
* Age: 9 -15 years.
* Teeth diagnosed as either vital (asymptomatic irreversible pulpitis or symptomatic irreversible pulpitis and the bleeding didn't stop after 5 minutes application of hemostatic agent) or non-vital pulp.

Exclusion Criteria

* Patients who are allergic to any drugs used in this study or with systemic illness
* Teeth that are grossly decayed or fractured and require post and core as final restorations
* Presence of periodontal pockets greater than 4 mm.
* Radiographical evidence of apical foramen less than 1 mm.
* Presence of periapical radiolucency exceeding 10 mm.
* Presence of external or internal root resorption.
* Patients with a history of major surgeries like cardiac, kidney transplantation, haemodialysis.
Minimum Eligible Age

9 Years

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kafrelsheikh University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hisham Mahmoud Hamdy Abada

lecturer at Endodontic department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hisham Abada, Doctors

Role: PRINCIPAL_INVESTIGATOR

Academic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

KafrelsheikhU

Kafr ash Shaykh, Kafr Elsheikh, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dina Sarhan, Masters

Role: CONTACT

01226083903

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dina Abdullah

Role: primary

01226083903

Hisham Abada

Role: backup

01003772427

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

663

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.